Uterine Hemorrhage: Clinical Trials

111 trials for Uterine Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

74 completed, 17 unknown, 8 recruiting, 5 terminated. 111 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3111Completed 74, Unknown 17, Recruiting 8, Terminated 5, Withdrawn 4, Not yet recruiting 3
Phase 28Completed 8

Follow Uterine Hemorrhage: new trials by email Literature Review of Uterine Hemorrhage trials Research Report on Uterine Hemorrhage

Trials (filtered) newest first · largest first

All 111 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Aspirin, Low-molecular-weight heparin - Venous Thromboembolism, Postpartum Period
Phase 3RecruitingUniversity of Calgary88052026-06-042026-07-27
Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH
tranexamic acid (1 g diluted in 100 mL of 0.9% saline, Normal (0.9%) saline - Post Partum Haemorrhage
Phase 3Not yet recruitingSultan Qaboos University882026-05-012026-04-01
to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
KLH-2109+ Leurprorelin acetate Placebo, KLH-2109 Placebo + Leurprorelin acetate - Menorrhagia, Uterine Fibroids
Phase 3RecruitingJW Pharmaceutical2542026-02-032026-05-01
EVE TRIAL , ALMA SYSTAM
Alma System - Postpartum Haemorrhage (PPH), PPH
Phase 3RecruitingResQ Medical Ltd502026-01-112026-03-30
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
Sublingual Misoprostol, IV Oxytocin - Postpartum Hemorrhage
Phase 3RecruitingStony Brook University13582025-01-272025-05-04
Comparison Between Preoperative Vaginal and Postoperative Sublingual Misoprostol for Prevention of Postpartum Hemorrhage During Cesarean Section
Misoprostol - Postpartum Hemorrhage
Phase 3Not yet recruitingAssiut University4002025-01-012025-01-09
Prophylactic Amnioinfusion for Prevention of Postpartum Hemorrhage
Saline delivered using an intrauterine pressure catheter (IUPC) - Postpartum Hemorrhage
Phase 3Not yet recruitingThe University of Texas Health Science Center, Houston7002024-11-112024-11-18
Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section
Tranexamic acid injection, Oxytocin - Cesarean Section Complications, Tranexamic Acid
Phase 3UnknownCairo University1502024-10-012024-09-05
Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women At Higher Risk
Tranexamic acid, Placebo - Postpartum Hemorrhage
Phase 3RecruitingLondon School of Hygiene and Tropical Medicine300002024-04-222025-03-11
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Relugolix, Relugolix placebo - Heavy Menstrual Bleeding, Uterine Fibroids
Phase 3RecruitingQilu Pharmaceutical Co., Ltd.1202024-01-152026-02-02
Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa
Tranexamic acid, 0.9% sodium chloride - Hemorrhage, Postpartum, Placenta Previa
Phase 3CompletedGuangzhou Medical University17322023-07-122025-03-27
Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.
BG2109, Placebo for BG2109, Placebo for add-back therapy - Uterine Fibroids, Heavy Menstrual Bleeding
Phase 3UnknownBio Genuine (Shanghai) Biotech Co., Ltd.3122022-12-162023-03-21
IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric], Ferrous Sulfate 65 mg elemental iron (325 mg tablets) - Anemia, Iron Deficiency, Uterine Bleeding
Phase 3RecruitingBaylor College of Medicine402022-09-152024-12-05
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
Calcium chloride, Saline placebo - Uterine Atony, Uterine Atony With Hemorrhage
Phase 3CompletedStanford University1202022-04-042024-06-11
Effect of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin
Tranexamic Acid, Calcium dobesilate (Doxium) - Heavy. Mentrual Bleeding, Abormal utèrine Bleeding
Phase 2 / Phase 3CompletedDistrict Headquarters Teaching Hospital Sahiwal1002022-01-012024-11-27
Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial
Recombinant Von Willebrand factor, Tranexamic Acid Injection [Cyklokapron] - Von Willebrand Diseases, Postpartum Hemorrhage
Phase 3CompletedNicoletta C Machin202021-06-042025-10-31
The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section
Tranexamic acid injection, Normal saline placebo - Postpartum Hemorrhage
Phase 3CompletedUniversity of Zimbabwe12262021-03-232023-03-20
Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT
sublingual Misoprostol, Intrauterine Misoprostol - To Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women
Phase 3CompletedDepartment of Medical Services Ministry of Public Health of Thailand1352020-10-302021-09-13
TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
Tranexamic Acid / Sodium chloride - Postpartum Hemorrhage
Phase 3RecruitingUniversity Hospital, Bordeaux13802020-08-072025-02-10
Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section
Tranexamic acid, Normal saline - Postpartum Hemorrhage, Tranexamic Acid
Phase 3CompletedKK Women's and Children's Hospital2002020-06-232022-11-09

Showing 20 of 111. Sign in to see all of them.

Narrower conditions

Postpartum Hemorrhage (52)  ·  Menorrhagia (44)  ·  Leiomyoma (26)  ·  Metrorrhagia (14)  ·  Hemorrhage (5)  ·  Placenta Previa (3)  ·  Anemia (2)  ·  Myofibroma (2)  ·  Pre-Eclampsia (2)  ·  Uterine Inertia (2)  ·  von Willebrand Diseases (2)  ·  Abortion, Habitual (1)  ·  Agranulocytosis (1)  ·  Anemia, Iron-Deficiency (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (111)  ·  Pathologic Processes (111)  ·  Pathological Conditions, Signs and Symptoms (111)  ·  Urogenital Diseases (111)  ·  Hemorrhage (106)  ·  Female Urogenital Diseases (59)  ·  Genital Diseases (59)  ·  Genital Diseases, Female (59)  ·  Uterine Diseases (59)  ·  Pregnancy Complications (53)  ·  Obstetric Labor Complications (52)  ·  Puerperal Disorders (52)  ·  Menstruation Disturbances (44)  ·  Neoplasms (26)

Interventions

Tranexamic Acid (27)  ·  Oxytocin (17)  ·  Misoprostol (14)  ·  Sodium Chloride (9)  ·  Estradiol (7)  ·  estradiol, norethindrone drug combination (7)  ·  asoprisnil (6)  ·  carbetocin (6)  ·  Levonorgestrel (5)  ·  Medroxyprogesterone Acetate (5)  ·  relugolix (5)  ·  Norethindrone Acetate (4)  ·  elagolix (4)  ·  Hysterectomy (3)  ·  Saline Solution (3)

Sponsors

Bayer (8)  ·  Abbott (6)  ·  Cairo University (6)  ·  AbbVie (4)  ·  Ain Shams University (4)  ·  Assiut University (4)  ·  Ferring Pharmaceuticals (4)  ·  Myovant Sciences GmbH (4)  ·  London School of Hygiene and Tropical Medicine (3)  ·  Allergan (2)  ·  Azienda U.S.L. 1 di Massa e Carrara (2)  ·  Gynuity Health Projects (2)  ·  ObsEva SA (2)  ·  Pharmacosmos A/S (2)  ·  Stanford University (2)

Countries

United States (35)  ·  Egypt (15)  ·  Canada (11)  ·  Czechia (7)  ·  Poland (7)  ·  Brazil (6)  ·  China (5)  ·  Hungary (5)  ·  South Africa (5)  ·  Denmark (4)  ·  France (4)  ·  Israel (4)  ·  Italy (4)  ·  Netherlands (4)  ·  Thailand (4)

Top investigators

Anna Chan (2)  ·  ObsEva SA (2)  ·  Yariv Yogev, professor (2)  ·  AbdelGany M Hassan (1)  ·  Ahmed N Afifi, MD (1)  ·  Ahmed N Shaker, MD (1)  ·  Alexander J Butwick, F.R.C.A. (1)  ·  Alicia V Aleman, MD (1)  ·  Amgad E. Abou-Gamrah, Ass.Prof. (1)

Results publications

PMID 33232518, PMID 34878624, PMID 36357960, PMID 37477173, PMID 37863160, PMID 39162220, PMID 21043553, PMID 21774563, PMID 22240178, PMID 23188490, PMID 30865281, PMID 30969201, PMID 31444600, PMID 31971678, PMID 33596357, PMID 33650259, PMID 34553161, PMID 34582715, PMID 35415708, PMID 35675604, PMID 36116480, PMID 37183454, PMID 39381651, PMID 39466126, PMID 40326221, PMID 40543832, PMID 11207490, PMID 15547547, PMID 16880310, PMID 17567419, PMID 17671809, PMID 18055721, PMID 18567277, PMID 18752459, PMID 19111789, PMID 19682342, PMID 20733445, PMID 20859150, PMID 20942615, PMID 21422847, PMID 21475963, PMID 21777897, PMID 21784734, PMID 21867401, PMID 22325113, PMID 22748952, PMID 22805300, PMID 22927764, PMID 22959906, PMID 23439617

NIH funding

2016 (3), 2017 (3), 2005 (1), 2009 (1), 2014 (1), 2018 (1), D43TW005492 (1), D43TW009343 (1), U01HL133815 (1)